Spv Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.84 Cr
as on 10-12-2024
- Paid Up Capital ₹ 3.81 Cr
as on 10-12-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 5.46%
(FY 2022)
- Profit -72.40%
(FY 2022)
- Ebitda -84.61%
(FY 2022)
- Net Worth 243.36%
(FY 2022)
- Total Assets -31.59%
(FY 2022)
About Spv Laboratories
The Corporate was formerly known as Spv Laboratories Opc Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.84 Cr and a paid-up capital of Rs 3.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanchit Garg, Vanshaj Garg, and Cyrus Patel serve as directors at the Company.
- CIN/LLPIN
U74140DL2015PTC374221
- Company No.
057015
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Spv Laboratories Private Limited offer?
Spv Laboratories Private Limited offers a wide range of products and services, including Health Conditions, Respiratory Care, Baby Care, Baby Skin Care, Ayurveda Products, Natural Hair & Skin Care.
Who are the key members and board of directors at Spv Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanchit Garg  | Director | 21-Mar-2016 | Current |
| Vanshaj Garg | Director | 25-Feb-2019 | Current |
| Cyrus Patel | Director | 13-Sep-2022 | Current |
Financial Performance of Spv Laboratories.
Spv Laboratories Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.46% increase. The company also saw a substantial fall in profitability, with a 72.4% decrease in profit. The company's net worth Soared by an impressive increase of 243.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spv Laboratories?
In 2021, Spv Laboratories had a promoter holding of 96.05% and a public holding of 3.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vsg Ventures Private LimitedActive 27 years 6 monthsSanchit Garg and Vanshaj Garg are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spv Laboratories?
Unlock and access historical data on people associated with Spv Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spv Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spv Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
